• Blood Centrifugation

    Sunstein prosecuted blood centrifugation patents for Haemonetics Corporation, a leader in the field of blood processing. The patented technologies allow blood components to be collected and processed for life-saving transfusions.

  • Purification

    Innovations by DEKA Research increase the efficiency of water purification systems, while reducing power and maintenance requirements. International patent applications like the one Sunstein prepared for DEKA can lead to worldwide adoption of a useful technology – one that can supply the developing world with access to safe water.

  • Shaft/hub

    Custom Machine & Tool Co. invented a novel shaft/hub connection device for precise component positioning and tight run-out control in demanding torque transmission applications such as timing-belt pulleys. Rigorous engineering analyses, as shown, demonstrate the benefits of CMT’s invention compared to other connection systems. The patent Sunstein obtained bolsters CMT’s position in a crowded marketplace.

  • Intravascular Stent

    Sunstein prosecuted a patent for a new stent that retains high radial strength but is more flexible and easier to insert into a patient’s coronary artery. The Crown™ stent is the product of our client DEKA’s collaboration with Cordis Corp., a Johnson & Johnson company, to improve the design of the Palmaz-Schatz® stent, the first intravascular stent proven to reduce blockage in arteries.

Patents. Juries. Success.

Exergen Corporation vs. Kaz, USA, Inc.

Sunstein lawyers won a $14.6M verdict for patent infringement following a two-week jury trial for our client Exergen, the people who pioneered the temporal artery thermometer.

Abbott Laboratories v Syntron Bioresearch, Inc.

In a case involving immunoassay technology, we obtained a jury verdict of patent infringement and a permanent injunction on behalf of Abbott Laboratories.

Our successful advocacy extends to patent reexaminations and interferences.

Winning at Post Grant Proceedings

Apple Inc., Google Inc., Motorola Mobility LLC v. Arendi S.A.R.L.

We won a rare Federal Circuit Court of Appeals reversal of an IPR decision of the Patent Trial and Appeal Board, which had invalidated our client’s patent claims. The Federal Circuit accepted our argument that the Board had improperly relied on a “common sense” observation to invalidate Arendi’s patent.

Click here to learn more about Sunstein litigators.

Spotlight on Patents

A recent patent we obtained for our client Nexsan, of Santa Clara, CA,  U.S. Patent No. 9218406 covers a private cloud storage system in which security is maintained by storing the data on devices (sold under the Transporter brand) of  individual users.  Data is shared on a peer-to-peer basis.  A central  server governs access based on user privileges without storing any of  the shared data. This patent has issued in one of the fields in which recent court rulings have been propelling rapid evolution of the law.

In the News

Our Latest Thinking

  • Robert M. Asher

    It used to be risky for a patent owner to lie in wait for several years before suing a suspected infringer. That risk is gone, now that the Supreme Court has struck down the laches defense to infringement suits.

    More...

  • Joel R. Leeman

    The designs on cheerleader uniforms are not high art, but they have enough pictorial quality independent of the uniforms to qualify for copyright protection. The Supreme Court’s decision brings cheer to the fashion industry.

    More...

  • Jonathan DeBlois

    It’s easy for an accused infringer to say the asserted patent is an obvious combination of existing innovations. It’s much less easy, however, to prove that a motivation to combine existed, which is critical to an obviousness defense.

    More...

Free Subscription

See more in Publications/News